Evidence map›Paper›PMID 36703087›Full record

ArticleClinical and experimental medicine2023

Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients.

Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhiyao Zhang, Yuan Jian, Wenming Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chuanying GengDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Guangzhong YangDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Huixing ZhouDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Huijuan WangDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Yanchen LiDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Yun LengDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Zhiyao ZhangDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Yuan JianDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Wenming ChenDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. 13910107759@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The basic activities of daily life may affect the prognosis of multiple myeloma (MM) patients and the Barthel index (BI) is currently the most widely used tool to evaluate basic activities of daily life, but few studies have evaluated its prognostic value in MM. We retrospectively enrolled patients with newly diagnosed MM and analyzed the association between the BI and the survival of newly diagnosed MM patients. We totally analyzed 538 patients and found that median overall survival (OS) and progression-free survival (PFS) were significantly shorter in the low BI (≤ 85) group compared with the high BI (> 85) group. Univariate Cox proportional hazards regression analysis showed that the low BI was associated with shorter OS and PFS. It was also confirmed that the low BI was poor prognostic factor for OS and PFS in multivariable analyses. In the propensity score matching analysis, patients with low BI also had shorter OS and PFS. Our study suggested that the low BI was a poor prognostic factor for patients with newly diagnosed MM.

Indexed as

Multiple MyelomaHumansPrognosisRetrospective StudiesBarthel indexMultiple myelomaPrognostic factorsSurvival

Identifiers

PMID36703087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.